The quality analysis of pharmacotherapy of patients with sciatica

Authors

  • L. V. Iakovlieva National University of Pharmacy, Ukraine
  • O. Ya. Mishchenko National University of Pharmacy, Ukraine
  • I. V. Konuschynska National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/cphj.16.1385

Keywords:

back pain, sciatica, pharmacotherapy, retrospective analysis of drug prescriptions, VEN analysis, frequency analysis

Abstract

The article presents the results of the rationality assessment for pharmacotherapy of patients with sciatica on the basis of pooled VEN/ frequency analysis. A retrospective analysis of medication administration records of 112 patients diagnosed with sciatica has been conducted. A total of 61 TNs (46INN) were prescribed to patients with sciatica. The total number of prescriptions was 964, the number of prescriptions per a patient – 8.6, indicating polypharmacy. The main directions of pharmacotherapy of patients with sciatica have been determined. They are anti-inflammatory and analgesic (non-opioid analgesics, NSAIDs, local anesthetics), antispasmodic (muscle relaxants), perfusion therapy to improve microcirculation and hemodynamics; they comply with the requirements of the current regulations – Clinical Protocol of medical care for patients with dorsalgia (2007). Comparison of the results of VEN and frequency analysis indicates that there are non-essential drugs with the metabolic action in the doctor’s prescriptions, such as deproteinized blood derivative (actovegin), L-lysine aescinat, etc. In case of prescribing a significant number of non-essential drugs with the metabolic action leading to polypharmacy the use of antisecretory drugs, in particular proton pump inhibitors, to prevent complications in the gastrointestinal tract, which may be caused by NSAIDs, is insufficient. A possible way to increase the rationality of pharmacotherapy of patients with sciatica is to reduce the number of prescriptions of non-essential drugs that will reduce the number of prescriptions to a patient.

References

Амелин А.В. // РМЖ. – 2013. – Специальный выпуск. Болевой синдром. Режим доступу: http:// www.rmj.ru/numbers_662.htm

Баринов А.Н. // РМЖ. – 2013. – Специальный выпуск. Болевой синдром. – Режим доступу: http:// www.rmj.ru/numbers_662.htm

Державний формуляр лікарських засобів / МОЗ України Держ. фармакол. центр; за ред. В.Т.Чумака. – К.: МОРІОН, 2013. – Вип. 5. – 1308 с.

Наказ МОЗ України №275 від 03.08.2007 р. Клінічний протокол надання медичної допомоги хворим на дорсалгії. – Режим доступу: http://www.dec.gov.ua/mtd/index.html

Морозов А.М., Яковлєва Л.В., Бездітко Н.В. та ін. Оцінка клінічної та економічної доцільності використання лікарських засобів у лікувально-профілактичному закладі (супровід формулярної системи): Метод. рекоменд. – Х.: Стиль-Издат, 2013. – 35 с.

Chen S.M., Liu M.F., Cook J. et al. // Int. Arch. Occup. Environ. Health. – 2009. – Vol. 82, №7. – Р. 797-806. Fig. 2. A – distribution of the prescribed drugs by INN for categories V – vital and N – non-essential; B – proportion of the drugs of categories V (vital) and N (non-essential) in the total number of prescriptions CLINICAL PHARMACY. – 2016. – Vol. 20, No. 2 21ISSN 1562-725X

Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society / Roger Chou, Vincenza Snow, J. Thomas Cross Jr. et al. // Clinical Guidelines. – Режим доступу : http://annals.org/ on 07/15/2015.

Hand L. Low back pain top cause of disability worldwide // Medscape Medical News from WebMD. March 24. – 2014. – Режим доступу: http://www.medscape.com/viewarticle/822492.

Heuch I., Hagen K., Heuch I. et al. // Spine (Phila Pa 1976). – 2010. – Vol. 35, №7. – P. 764-768.

Hoy D., March L., Brooks P. et al. // Ann. Rheum. Dis. – 2014. – Vol. 73, №6. – P. 968-974.

Luo X., Pietrobon R., Sun S.X. et al. // Spine. – 2004. – Vol. 29, №1. – P. 79-86.

Roelofs P.D., Deyo R.A., Koes B.W. et al. // Spine (Phila Pa 1976). – 2008. – Vol. 33, №16. – P. 1766-1774.

United States Preventative Task Force, 2012. Health care guideline: Adult acute and subacute low back pain. Institute for Clinical System Improvement. – Режим доступу: https://www.icsi.org/_asset/bjvqrj/LBP.pdf

Downloads

Published

2016-06-14

Issue

Vol. 20 No. 2 (2016)

Section

Pharmacoeconomics

License

Copyright (c) 2016 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).